Companies: 10,795·Total market cap: $144.5T
Boston Scientific Corporation

Boston Scientific Corporation

BSXNYSEHealthcare● Active
$48.74
+$0.19(+0.39%)
Market Cap$72.4B
P/E Ratio—
52W High$109.5
52W Low$47.17
Cash on HandFinancialsRevenue

Boston Scientific Corporation (BSX) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

BSX · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$2.04B▲ +394.0% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$2.04B
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+394.0%
vs prior fiscal year
Latest Quarter
$1.52B
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$2.04BCash on Hand
Total Debt$12.42BTotal Debt
Net Cash / Net Debt−$10.37BNet Debt Position
Cash vs Debt Ratio
Cash 14%Debt 86%

Boston Scientific Corporation carries a net debt position of $10.37B. Total debt ($12.42B) exceeds cash on hand ($2.04B). Boston Scientific Corporation cash vs debt ratio: 14% cash / 86% debt.

Net Cash = Cash & ST Investments − Total Debt$2.04B − $12.42B = −$10.37B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
BSX annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$2.04B+394.0%
Dec 31, 2024$414.0M-52.1%
Dec 31, 2023$865.0M-6.8%
Dec 31, 2022$928.0M-51.8%
Dec 31, 2021$1.93B+11.0%
BSX cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Boston Scientific Corporation
Boston Scientific CorporationYOU
BSX
$2.04B2.8%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Boston Scientific Corporation (BSX) cash on hand as of December 31, 2025 is $2.04B, comprising $2.04B in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Boston Scientific Corporation cash and short-term investments on the balance sheet (10-K filing). Also referred to as Boston Scientific Corporation cash reserves or cash position.

Boston Scientific Corporation annual cash on hand history shows increased +394.0% in 2025: increased +394.0% in 2025. Boston Scientific Corporation cash reserves in 2025 reflect the company's capital allocation strategy.

Boston Scientific Corporation carries total debt of $12.42B against cash of $2.04B, resulting in a net debt position of -$10.37B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

BSX cash on hand · 5 questions

As of December 31, 2025, Boston Scientific Corporation (BSX) has $2.04B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $2.04B in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $1.52B. Data sourced from the annual 10-K filing via FMP.

BSX cash on handBSX cash reservesBSX cash 2025how much cash does BSX have

▸ Source: FMP /balance-sheet-statement · US GAAP · Boston Scientific Corporation · Boston Scientific Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025